Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Last Updated on: 22 February, 2024|Author: Getaka | Social: X Twitter Profile

Fundamental Analysis of India Glycols Ltd

About the Company - India Glycols Ltd

India Glycols Ltd. is a Public Limited Listed company incorporated on 19/11/1983 and has its registered office in the State of Uttarakhand/Uttaranchal, India. Company’s Corporate Identification Number(CIN) is L24111UR1983PLC009097 and registration number is 009097. Currently Company is involved in the business activities of Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids; chemically pure suger etc.. Company’s Total Operating Revenue is Rs. 2863.23 Cr. and Equity Capital is Rs. 30.96 Cr. for the Year ended 31/03/2022.
Chemicals - Organic - Alcohol BasedA-1, Industrial Area, Bazpur Road, Udham Singh Nagar Uttarakhand/Uttaranchal
NamePosition Held
Mr. U S BhartiaChairman & Managing Director
Mr. Sudhir AgarwalExecutive Director
Mr. Pragya Bhartia BarwaleExecutive Director
Mr. Pradip Kumar KhaitanIndependent Director
Mr. Jitender BalakrishnanIndependent Director
Mr. Ravi JhunjhunwalaIndependent Director
Mr. Jagmohan N KejriwalIndependent Director
Mr. Sajeve Bhushan DeoraIndependent Director
Ms. Shukla WassonIndependent Director
Mrs. Jayshree BhartiaDirector

India Glycols Ltd. Share Price Update

Share PriceValue
Previous Day₹843.80

Basic Stock Data of India Glycols Ltd

Market Cap 2,700 Cr.
Current Price 872
High / Low979/512
Stock P/E15.8
Book Value 635
Dividend Yield0.86 %
ROCE8.39 %
ROE5.94 %
Face Value 10.0

Data Source:

India Glycols Ltd Quarterly Results

MonthSep 2020Dec 2020Mar 2021Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023
Operating Profit666887556655806368679610096
OPM %12%10%12%8%8%7%12%8%10%12%16%15%12%
Other Income914182521714-91693561212
Profit before tax353962269473132353153466450
Tax %23%24%-14%21%21%23%-111%20%25%6%13%20%24%
Net Profit273071211372467282450405138
EPS in Rs8.589.6322.9368.3012.047.7521.679.378.089.9313.0216.5212.28

India Glycols Ltd Quarterly Chart

India Glycols Ltd Profit & Loss

MonthMar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023TTM
Operating Profit335370203124175237322416303291269305358
OPM %12%11%7%5%8%9%11%12%11%13%9%12%14%
Other Income2210-174-16-477231724152605464
Profit before tax120140-212-144-8145147213153143379165213
Tax %44%32%24%38%30%22%34%38%25%8%10%15%
Net Profit6796-161-89-573597133115132340141179
EPS in Rs30.85-52.12-28.63-18.3511.3231.1842.8337.0342.51109.7740.4051.75
Dividend Payout %12%19%-2%0%0%9%13%14%16%14%7%19%

India Glycols Ltd Profit & Loss Yearly Chart

India Glycols Ltd Growth

Compounded Sales Growth
10 Years:-3%
5 Years:-3%
3 Years:-1%
Compounded Profit Growth
10 Years:1%
5 Years:3%
3 Years:-6%
Stock Price CAGR
10 Years:25%
5 Years:29%
3 Years:26%
1 Year:40%
Return on Equity
10 Years:9%
5 Years:11%
3 Years:10%
Last Year:6%

India Glycols Ltd Balance Sheet

MonthMar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Sep 2023
Equity Capital28313131313131313131313131
Preference Capital000000000050
Other Liabilities5118138185931,6651,6451,7421,8212,0531,8141,7971,8452,044
Total Liabilities3,0863,1183,2433,1543,6203,4923,4213,7844,0864,1194,6314,8585,119
Fixed Assets1,1911,2161,3091,1462,0292,1112,1562,1732,2282,1932,3182,7172,814
Other Assets1,7731,5261,7921,8431,3821,2651,1521,4531,6601,7741,7341,6981,878
Total Assets3,0863,1183,2433,1543,6203,4923,4213,7844,0864,1194,6314,8585,119

India Glycols Ltd Reserves and Borrowings Chart

India Glycols Ltd Cash Flow

MonthMar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023
Cash from Operating Activity -24817-234-1711,231302502147343137116326
Cash from Investing Activity -200-227110175-78-40-103-128-151-14876-330
Cash from Financing Activity 240-58287-4-1,168-263-3993-21611-189-1
Net Cash Flow178-38-0-15-1-022-23-04-5

India Glycols Ltd Financial Efficiency Indicators

MonthMar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023
Debtor Days403254625757403576575159
Inventory Days1499210910912812987124146166148209
Days Payable53839155120144152143155158137209
Cash Conversion Cycle13640721156642-251767656260
Working Capital Days885078906612-811193430
ROCE %12%12%5%3%5%9%15%20%14%10%9%8%

India Glycols Ltd Financial Efficiency Indicators Chart

India Glycols Ltd Share Holding Pattern

MonthDec 2020Mar 2021Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023
No. of Shareholders35,55634,58836,70943,44139,98543,32943,21143,15942,82342,86943,85347,476

India Glycols Ltd Shareholding Pattern Chart

No. of India Glycols Ltd Shareholders

India Glycols Ltd Mutual Fund Holdings

Fund NameNo of SharesAUM (%)Amount Invested (Cr)
Motilal Oswal Nifty Microcap 250 Index Fund116670.170.78
Groww Nifty Total Market Index Fund270.010

India Glycols Ltd ROCE Trend

India Glycols Ltd EPS Trend

India Glycols Ltd Key Financial Ratios

MonthMar 23Mar 22Mar 21Mar 20Mar 19
Basic EPS (Rs.)45.55109.7742.5137.0342.83
Diluted EPS (Rs.)45.55109.7742.5137.0342.83
Cash EPS (Rs.)72.23128.9568.1562.2067.77
Book Value[Excl.RevalReserv]/Share (Rs.)614.12572.46377.41333.92310.91
Book Value[Incl.RevalReserv]/Share (Rs.)614.12572.46377.41333.92310.91
Revenue From Operations / Share (Rs.)856.18926.41748.35883.501084.12
PBDIT / Share (Rs.)103.1789.3891.4992.88140.11
PBIT / Share (Rs.)72.8263.4565.6167.84115.48
PBT / Share (Rs.)49.62112.4438.6836.5469.14
Net Profit / Share (Rs.)41.88103.0242.2737.1643.14
NP After MI And SOA / Share (Rs.)40.40109.7742.5137.0342.83
PBDIT Margin (%)12.049.6412.2210.5112.92
PBIT Margin (%)8.506.848.767.6710.65
PBT Margin (%)5.7912.
Net Profit Margin (%)4.8911.125.644.203.97
NP After MI And SOA Margin (%)4.7111.845.684.193.95
Return on Networth / Equity (%)6.5718.9611.2611.0813.77
Return on Capital Employeed (%)7.536.818.639.9917.36
Return On Assets (%)2.577.333.192.803.50
Long Term Debt / Equity (X)0.280.300.430.390.41
Total Debt / Equity (X)0.570.580.840.860.89
Asset Turnover Ratio (%)0.550.680.550.690.94
Current Ratio (X)0.880.910.960.800.80
Quick Ratio (X)0.470.520.620.460.42
Inventory Turnover Ratio (X)2.002.571.841.792.84
Dividend Payout Ratio (NP) (%)18.565.460.0039.0611.25
Dividend Payout Ratio (CP) (%)10.604.420.0023.307.14
Earning Retention Ratio (%)81.4494.540.0060.9488.75
Cash Earning Retention Ratio (%)89.4095.580.0076.7092.86
Interest Coverage Ratio (X)3.203.973.402.973.02
Interest Coverage Ratio (Post Tax) (X)
Enterprise Value (Cr.)2881.374053.872184.041458.931613.16
EV / Net Operating Revenue (X)1.091.410.940.530.48
EV / EBITDA (X)9.0214.657.715.073.72
MarketCap / Net Operating Revenue (X)0.711.090.550.240.25
Retention Ratios (%)81.4394.530.0060.9388.74
Price / BV (X)0.991.751.100.630.89
Price / Net Operating Revenue (X)0.711.090.550.240.25

India Glycols Ltd Profitability Ratios (%)

India Glycols Ltd Liquidity Ratios

India Glycols Ltd Liquidity Ratios (%)

India Glycols Ltd Interest Coverage Ratios (%)

India Glycols Ltd Valuation Ratios

Fair Value of India Glycols Ltd Stock

Fair Value: ₹601.09

The stock is overvalued by 31.07% compared to the current price ₹872

*Investments are subject to market risks

Strength and Weakness of India Glycols Ltd Stock

  1. The company has higher reserves (950.77 cr) compared to borrowings (0.38 cr), indicating strong financial stability.
  2. The company has shown consistent growth in sales (2.23 cr) and profit (98.54 cr) over the years.
  1. The stock is trading at a high valuation with an average P/B ratio of 77.04 and average Dividend Yield of 8.48%.
  2. The stock has a low average ROCE of 10.17%, which may not be favorable.
  3. The stock has a high average Working Capital Days of 38.42, which may not be favorable.
  4. The stock has a high average Cash Conversion Cycle of 59.75, which may not be favorable.

About the Author

Author Avatar

Getaka, CFA, a financial analyst with 15 years of experience in the industry. Getaka holds an MBA degree and the Chartered Financial Analyst designation, demonstrating his profound understanding of financial analysis and investment management. Throughout his career, he has conducted numerous financial analyses and due diligence processes for companies in the industry, and has a strong track record of identifying key trends and opportunities. He leverages his expertise to deliver a thorough financial analysis of a company, encompassing its financial performance, key ratios, future prospects, and risks. Getaka is committed to providing accurate, reliable, and trustworthy information to help readers make informed decisions about their finances and investments.

Disclaimer: This article is for informational purposes only and should not be construed as financial advice. The author is not a SEBI registered financial advisor and does not have any vested interest in India Glycols Ltd. Investors are advised to conduct their own due diligence and consult with a financial professional before making any investment decisions. The information provided in this article is based on publicly available data and the author's analysis, but it may not be comprehensive or up-to-date. The author and are not responsible for any errors or omissions in the content. This article is not intended to promote any particular investment strategy or recommendation, and readers should consult with their own financial advisors before making any investment decisions. Data Source: NSE